Purchase Order 75N94024P00181
Award Date 3/1/24
Potential Completion Date 6/1/24
Potential Value $15K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Tonawanda, NY 14150, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $91,897.70 firm fixed-price delivery order to Pine Pharmaceuticals LLC for the procurement of intravenous stable isotope glucose (6,6 deuterated glucose) to support metabolic research. The contract, awarded on December 18, 2025, with an ultimate completion date of May 31, 2026, was issued without a set-aside designation. Pine Pharmaceuticals, an FDA-registered 503B outsourcing facility located in Tonawanda,...
- The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the Department of Health and Human Services, awarded a $44,606.40 firm fixed-price purchase order to Pine Pharmaceuticals LLC, a small business contractor located in Tonawanda, New York. The contract is for the acquisition of intravenous stable isotopes, specifically D5 glycerol and 6,6 D2-glucose, to support metabolic research. This award is not associated with a larger contract vehicle. The contract has a...
- This is a $81,714.96 firm fixed-price delivery order contract awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency within the U.S. Department of Health and Human Services, to Pine Pharmaceuticals LLC, a for-profit limited liability company located in Tonawanda, New York. The contract is for the provision of intravenous stable isotope glucose (D5 glycerol) to support metabolic research. The contract has an ultimate completion date of April 30,...
- The National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases awarded a $237,922.80 firm fixed price purchase order to Pine Pharmaceuticals LLC. The purpose of this acquisition is to procure an intravenous stable isotope to support metabolic research studies being conducted by the funding agency. The solicitation sought a stable isotope that meets NIH specifications for use in clinical human research, referencing a history of safe use in such studies. No...
- This is a firm fixed-price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the U.S. Department of Health and Human Services, to Pine Pharmaceuticals LLC, a for-profit limited liability company located in Tonawanda, New York. The $12,580.80 contract is for the acquisition of intravenous stable isotopes, which are specialized pharmaceutical compounds used in metabolic and clinical research studies. Pine Pharmaceuticals is an...
- This is a $125,812.80 firm-fixed-price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to Pine Pharmaceuticals LLC, a for-profit limited liability company. The contract is for the acquisition of intravenous stable isotopes, specifically 6,6 deuterated glucose and d5 glycerol, to support metabolic research conducted by NIDDK. The contract was awarded on a non-competitive, sole-source basis, as Pine Pharmaceuticals is the only approved...
- This is a firm-fixed-price purchase order awarded by the National Institute of Child Health and Human Development (NICHD), an agency within the U.S. Department of Health and Human Services (HHS), to Pine Pharmaceuticals LLC for the procurement of intravenous stable isotope (6,6 D2-Glucose) for metabolic research. The $138,712.14 contract has an ultimate completion date of November 2, 2024 and was awarded on a sole-source basis without a small business set-aside. Pine Pharmaceuticals is an...
- This is a $121,989 firm fixed-price purchase order awarded by the National Institute on Deafness and Other Communication Disorders (NIDCD), a civilian agency within the U.S. Department of Health and Human Services (HHS), to Pine Pharmaceuticals LLC, a for-profit limited liability company located in Tonawanda, New York. The contract is to provide specialized pharmaceutical products and services, including the manufacture of stable isotopes, placebo capsules, and other compounds used in medical...
- This is a firm fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), part of the U.S. Department of Health and Human Services, to Pine Pharmaceuticals LLC, a for-profit limited liability company in Tonawanda, New York. The contract, valued at $119,062.95, is for the production of drug capsules. The award does not have a set-aside designation. Pine Pharmaceuticals is an FDA-registered 503B outsourcing facility that specializes in pharmaceutical compounding,...
- This federal contract award was made by the National Institute on Alcohol Abuse and Alcoholism (NIAAA), a civilian agency within the U.S. Department of Health and Human Services (HHS), to Pine Pharmaceuticals LLC, a for-profit limited liability company located in Tonawanda, New York. The $173,631.31 firm fixed-price purchase order was awarded on September 22, 2016, with a completion date of September 21, 2017. The contract is for the provision of a drug necessary for use in the NCATS II...